After surgery for colorectal cancer, the clinical work does not stop. A five-year surveillance window begins the day a patient leaves the operating room. That window requires CEA blood tests, CT imaging, and colonoscopy - often managed across surgical oncology, medical oncology, gastroenterology, and radiology simultaneously.
The protocol is well-defined in clinical literature. But coordination remains a challenge at most clinics.
What Standard Surveillance Requires
Clinical guidelines from major oncology bodies recommend the following after surgery to remove colorectal cancer:
- CEA measurements every 3 to 6 months during the first three post-surgery years
- CT imaging of the chest, abdomen, and pelvis annually for the first three years
- A repeat colonoscopy at one year post-surgery, then every three to five years if findings are normal
Each element targets a different failure mode. Rising CEA trends may signal hepatic or systemic spread before imaging confirms it. CT scans detect pulmonary and peritoneal recurrence. Colonoscopy surveys for metachronous primary tumors.
These three surveillance streams must be coordinated across departments that often lack shared systems and clear accountability for keeping the full protocol on track.
Recurrence Rates Frame the Stakes
Colorectal cancer recurs more often than many clinic teams expect. Available data on recurrence patterns shows that recurrent disease appears in approximately 9.9% of patients by year one, 26.2% by year three, and 31.5% by year five. (PMC, 2023)
The first three years carry the highest density of recurrence risk. That is also when surveillance adherence tends to be most consistent - but the baseline is lower than guidelines intend. Studies at NCI-designated comprehensive cancer centers found overall adherence to the full recommended protocol was 23%. Adherence to CEA monitoring, CT imaging, and colonoscopy individually each fell below 50%. (PMC, 2018)
These are comprehensive cancer centers - institutions with more resources, structured care teams, and protocol infrastructure than most community oncology practices. If these facilities perform at 23% overall adherence, the gap in community settings is likely wider.
The Coordination Architecture That Creates Gaps
Post-surgery colorectal cancer surveillance spans at least three clinical departments. Understanding why adherence breaks down requires examining where scheduling authority and clinical information actually sit.
In most clinic environments, the surgeon closes the loop on the immediate post-surgery period. Medical oncology picks up adjuvant chemotherapy where indicated. But the long-term surveillance plan - who schedules the year-one colonoscopy, who orders CEA at month three, who reviews the year-two CT - often has no designated owner. Responsibility floats across surgical oncology, medical oncology, and the gastroenterology team that will perform the scope.
When a patient calls to book a follow-up, they may reach a scheduler who may not know the surgical date or have access to prior CEA results. The scheduler books what the patient requests, not what the protocol requires.
The problem is structural, not staffing-related. Without a shared surveillance timeline that all teams can view and update, coordination defaults to ad hoc communication. Lab results and imaging reports may sit in inboxes that the primary oncologist does not review between appointments. A clinical navigation program presented at ASCO 2026 identified automated reminder prompts for surveillance and diagnosis-specific follow-up triggers in the electronic record as high-priority fixes named by both patients and providers. (ASCO, 2026)
Where Rectal Cancer Surveillance Faces Additional Pressure
For rectal cancer patients managed nonoperatively after a clinical complete response to chemoradiation, the surveillance protocol is more intensive - and adherence is lower still. Data from this population shows that only 39% of patients achieved all NCCN-recommended surveillance in year one. By year five, that figure had fallen to 15%. (PMC, 2024)
More frequent imaging and closer clinical review create more touchpoints. More touchpoints mean more scheduling events, more handoffs, and more opportunities for delays. The pattern mirrors the post-surgery population, but the clinical tolerance for a missed scan is narrower.
What a Platform-Level Solution Looks Like
Clinic administrators and IT leads evaluating oncology software often focus on EHR connectivity and billing integration. Surveillance coordination requires a different lens.
The key question: Does the software surface follow-up dates to every relevant team member, flag when a milestone is approaching, and alert the care team when a result has not been reviewed within the expected window?
A treatment-timeline architecture - rather than a standard appointment calendar - creates that structural difference. When a surgical date is recorded and the surveillance protocol is attached to it, every downstream milestone generates a scheduled task with an assigned owner. The system doesn't wait for patients to call. For more on this distinction, see our post on why oncology clinics need treatment timelines, not just calendars.
CEA result trending is a second concrete gap. A single CEA value has limited diagnostic utility in isolation. A rising trend across three or four consecutive draws tells a different story. Data on CEA as a postoperative surveillance marker shows that regular monitoring every 3 to 6 months may support earlier detection of recurrence - but that benefit only materializes when tests actually run on schedule. (PMC, 2025) Clinics that store CEA results as static lab reports - one file per draw, without cross-reference - push the work of reconstructing the trend onto the oncologist at every visit. Software that automatically extracts and displays these values reduces the time to clinical insight. See our post on how AI lab extraction changes clinical routine for more on this approach.
Cross-provider visibility matters for the colonoscopy component in particular. When the gastroenterology team books a scope, the surgical oncologist should see that booking without placing a phone call. When the scope is complete and the pathology report is signed, the result should surface in the oncologist's workflow before the next scheduled visit. These are workflow requirements that demand better data integration.
A Pattern Seen Across Surveillance-Heavy Cancers
Colorectal cancer surveillance is one of several cancer types where post-surgery adherence falls short of protocol. Clinics managing pancreatic cancer patients encounter similar protocol complexity and dropout patterns across multi-year follow-up windows. The structural problems are parallel. See Pancreatic Cancer Surveillance Failures and What Works for a detailed breakdown.
The pattern is consistent: well-designed protocols can't guarantee compliant care when scheduling is fragmented across departments. Reminder emails have limited impact. Structural change to how surveillance plans are owned and tracked is what closes the gap.
Three Operational Questions to Audit Now
If your clinic manages post-surgery colorectal cancer patients, three questions are worth examining in your current workflow:
- Who owns the five-year surveillance plan after the surgical team discharges the patient? If the answer defaults to the patient, your adherence numbers are likely lower than the guideline target.
- Can every team member with clinical responsibility for a given patient see the full surveillance timeline - including completed, pending, and overdue items? If that information lives in one clinician's note, coordination depends on memory and phone calls.
- How long does it take for a CEA result to appear in the clinical view of the ordering oncologist after the lab signs it? A gap of more than 24 hours creates avoidable clinical risk.
You can answer these without buying software, but they define what any software solution needs to address.
Demos take 30 minutes. We will walk you through Rucja's surveillance timeline feature using your live hospital data, including CEA trend tracking and cross-team scheduling visibility. Book a demo.